Scientists from Nanyang Technological University (NTU) Singapore have developed an antibody which boosts the survival chances for patients suffering from influenza and pneumonia. Proven effective in lab tests, the antibody is now being made suitable for use in humans. The scientists are also using the new antibody to develop a diagnostic kit which can help doctors accurately track the recovery progress of flu and pneumonia patients.
Sage Products LLC has partnered with National Patient Safety Foundation (NPSF) to convene an expert committee to guide study of non-ventilator associated hospital-acquired pneumonia.
Two common and sometimes dangerous respiratory diseases, a viral one caused by respiratory syncytial virus (RSV), and a bacterial one caused by Streptococcus pneumoniae may be linked, suggests a study published in this week's PLOS Medicin
HIV-positive children in developing countries are six times more likely to die from pneumonia than children without the virus, research suggests.
The program will provide clear strategies for preventing NV-HAP in hospitalized patients. It is open to both VHA members and non-VHA members and is supported by an independent educational grant from Sage Products, LLC.
Extra vitamin E protected older mice from a bacterial infection that commonly causes pneumonia. Microbiologists and nutrition researchers from Tufts University report that the extra vitamin E helped regulate the mice's immune system.
In Tennessee, the introduction in 2010 of a new pneumococcal vaccine for infants and young children coincides with a 27 percent decline in pneumonia hospital admissions across the state among children under age 2.
Many different microbes can cause pneumonia, and treatment may be delayed or off target if doctors cannot tell which bug is the culprit.
Poor oral health and hygiene are increasingly recognized as major risk factors for pneumonia among the elderly.
In a randomized clinical trial of antibiotic treatments for community-acquired pneumonia (CAP), researchers did not find that monotherapy with ß-lactam alone was worse than a combination therapy with a macrolide in patients hospitalized w